Live

Novo stock falls as much as 7% despite $23 billion sales target for blockbuster obesity drugs

The True Post icon
By The True Post
No Comments
Novo stock falls as much as 7% despite $23 billion sales target for blockbuster obesity drugs

The Danish company seeks to convince investors it can compete in an increasingly crowded field it helped pioneer.

Source: CNBC

Share This Article
The True Post icon
ByThe True Post
The newsroom of The True Post.
Leave a Comment

Related Stories

Uncover the stories that related to the post!
Jim Cramer's top 10 things to watch in the stock market Friday
Live

Jim Cramer's top 10 things to watch in the stock market Friday

Charles Spencer on the royal fallout following Princess Diana's death
Live

Charles Spencer on the royal fallout following Princess Diana's death

Elon Musk’s data center sued for $30 million by family of worker killed at site
Live

Elon Musk’s data center sued for $30 million by family of worker killed at site

Florida parents say their baby has wrong father after a clinic's IVF mistake
Live

Florida parents say their baby has wrong father after a clinic's IVF mistake

Charles Spencer's striking claims about the royal fallout following Princess Diana's death
Live

Charles Spencer's striking claims about the royal fallout following Princess Diana's death

Trump planning sanctions against International Criminal Court over Netanyahu arrest warrant: report
Live

Trump planning sanctions against International Criminal Court over Netanyahu arrest warrant: report

Early voting for midterm elections begin in some states
Live

Early voting for midterm elections begin in some states

'I don't know why he did it': House Majority Leader Scalise on White House press ban
Live

'I don't know why he did it': House Majority Leader Scalise on White House press ban

Show More